Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Frontier Carbon Corporation is a leading materials science company specializing in the large-scale production and application of fullerenes, a unique form of carbon with significant potential in life sciences. A joint venture between Mitsubishi Chemical and Mitsubishi Corporation, the company utilizes proprietary combustion synthesis technology to manufacture high-purity C60 and C70 fullerenes under the brand name Nanom. In the healthcare sector, Frontier Carbon is best known for its Radical Sponge line of fullerene-based antioxidants, which are used in high-end skincare to neutralize reactive oxygen species and prevent skin aging. The company also supports research into fullerene-based drug delivery systems and therapeutic agents for oxidative stress-related diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Frontier Carbon.